☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Oxford BioMedica
Oxford Biomedica Signs Three Year Master Services & Development Agreement with Astrazeneca to Manufacture COVID-19 Vaccines
July 4, 2022
PharmaShots Weekly Snapshots (October 18 - 22, 2021)
October 22, 2021
AstraZeneca Expands Supply Agreement with Oxford Biomedica for AZD1222 to Combat COVID-19
September 1, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.